| Concomitant |
| Prophylaxis |
22.6% |
| Product Used For Unknown Indication |
21.9% |
| Drug Use For Unknown Indication |
7.8% |
| Constipation |
6.5% |
| Renal Transplant |
4.7% |
| Electrolyte Substitution Therapy |
4.6% |
| Hypertension |
4.4% |
| Cancer Pain |
2.5% |
| Ventricular Tachycardia |
2.5% |
| Insomnia |
2.3% |
| Pneumonia |
2.3% |
| Infection Prophylaxis |
2.2% |
| Sepsis |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Diabetes Mellitus |
2.1% |
| Neoplasm Malignant |
1.8% |
| Nutritional Support |
1.8% |
| Pain |
1.8% |
| Schizophrenia |
1.8% |
| Fluid Replacement |
1.7% |
|
| Platelet Count Decreased |
7.2% |
| Ventricular Tachycardia |
7.2% |
| Sepsis |
6.0% |
| Shock |
6.0% |
| Somnolence |
6.0% |
| Stomatitis |
6.0% |
| Surgery |
6.0% |
| White Blood Cell Count Increased |
6.0% |
| Disseminated Intravascular Coagulation |
4.8% |
| Hepatic Failure |
4.8% |
| Hepatic Function Abnormal |
4.8% |
| Renal Disorder |
4.8% |
| Septic Shock |
4.8% |
| Back Pain |
3.6% |
| Cerebral Infarction |
3.6% |
| Interstitial Lung Disease |
3.6% |
| Intra-abdominal Haematoma |
3.6% |
| Nikolsky's Sign |
3.6% |
| No Adverse Event |
3.6% |
| Pancytopenia |
3.6% |
|
